Microbiome And Health Insights

Today, I’m thrilled to share what I believe is the biggest breakthrough in microbiome science for a decade. Nature Magazine, the world's most influential scientific journal, has just published a scientific paper by ZOE's scientists, establishing the first reliable, repeatable, global way to measure the health of an individual’s gut microbiome. It represents the culmination of eight years of work at ZOE. Scientists have been trying to solve this puzzle for more than 20 years, right back to when they first discovered how important our gut microbes are for our health. It’s been achieved only because more than 34,000 ZOE members took part in this research. We’ve known for a long time that the microbiome is linked to cholesterol, inflammation, blood sugar control and even how we store fat. But we’ve never had a clear, evidence-based way to measure how healthy a microbiome actually is. This analysis finally delivers it, revealing a global ranking of microbes that works across populations, diets and environments. The insights are remarkable. Among the top 50 “good microbes” linked with better health, 22 were completely unknown to science until today, and most of the others have never been successfully grown in a lab. We also discovered clear links between these good microbes and health outcomes: healthy individuals carry around 3.6 more of these beneficial species, and people at a healthy weight carry about 5.2 more than those living with obesity. We also found a strong connection to diet. People eating healthier diets consistently have microbiomes that score better on this ranking. What we eat shapes our gut health, and now we can measure this relationship with unprecedented clarity. ZOE was created to enable microbiome research at a scale that traditional science has been unable to fund, and use this research to create actionable advice that can transform our gut health. This is a major milestone in that journey. I’m delighted to say that as a result, this breakthrough science is immediately available for the public to investigate their own microbiome through ZOE’s new Gut Health Test in the UK, and this is coming soon in the US. You can now receive not only a reliable measurement of how healthy your microbiome is as you change their diet, but also discover the health of clusters of gut microbes in your gut affecting metabolism, inflammation and more. To all our amazing ZOE members who have participated in our science: you made this possible. You are transforming our understanding of the microbiome. Thank you so much. I hope you feel as proud and excited as I do. I should note that your research is now published in Nature, which is the ultimate scientific accolade, and you can definitely brag about that with your friends! If you think this science could help others understand their health, I’d love for you to share it. You’ll find links to more details from our findings and access to the paper in the comments.

How do you live to 117 without major diseases? #MySummary This study is a deep biological dive into a 117-year-old supercentenarian women, creating a "multi-omics blueprint" of her extraordinary lifespan. Researchers looked at almost everything: her genes, immune system, metabolism, epigenetics (how genes are expressed), and gut microbiome. In one hand, she had clear molecular signs of advanced age, like extremely short telomeres (the protective caps on our chromosomes) and age-related mutations in her blood. But on the other hand, she had a powerful set of "youthful" features that protected her from the diseases that typically accompany aging: 🔹A "Young" gut microbiome: Her gut was teeming with beneficial bacteria, particularly Bifidobacterium, at levels seen in much younger, healthier people. This is the opposite of the typical decline seen with age and is strongly linked to low inflammation. Intriguingly, she ate yogurt daily. 🔹Decelerated "Epigenetic Clocks": Her cells behaved as if they were biologically 15-20 years younger than her actual age. 🔹A low-inflammation profile: Her blood showed very low levels of key inflammatory markers, protecting her from chronic disease. 🔹Resilient genetics: She possessed rare genetic variants associated with enhanced immune function, cardiovascular health, and neuroprotection. Essentially, her body successfully "decoupled" the process of aging from the process of getting sick. #Mythoughts It's clear that it isn't one single "magic bullet" but a combination of factors. While she won a bit of the genetic lottery, her lifestyle, like a Mediterranean diet, likely played a crucial role in cultivating a youthful, anti-inflammatory gut microbiome. This microbiome, in turn, helped keep systemic inflammation low, protecting her from cardiovascular disease and other ailments. The idea that we can be a mosaic of different biological ages is profound. Your chronological age is just a number. The "age" of your microbiome or your epigenome might be far more important for your healthspan. HAPPY to hear your thoughts and stay VITAL! #MyInspiration "The whole is greater than the sum of its parts." - Aristotle Paper is published in Cell Reports Medicine: https://lnkd.in/eb9wGzrf #microbiome #longevity #aging #health #genetics #epigenetics #science #biotech #nutrition #probiotics

One of the most overlooked stroke risk factors isn't in your arteries. It's in your gums. Researchers analyzing blood clots from stroke patients found oral bacteria DNA within the blockages. Not just present. Biologically capable of contributing to the blockage itself. 𝗛𝗢𝗪 𝗚𝗨𝗠 𝗗𝗜𝗦𝗘𝗔𝗦𝗘 𝗥𝗘𝗔𝗖𝗛𝗘𝗦 𝗧𝗛𝗘 𝗕𝗥𝗔𝗜𝗡 This isn't just correlation. It's a biologically plausible pathway, backed by human and experimental evidence. ↳ P. gingivalis (a key gum disease bacterium) enters the bloodstream when gums bleed ↳ Triggers systemic inflammation ↳ Damages arterial walls ↳ Accelerates plaque formation ↳ Plaques block blood flow → stroke Bleeding gums aren't just a local problem. They're a systemic vascular signal. 𝗧𝗛𝗘 𝗘𝗩𝗜𝗗𝗘𝗡𝗖𝗘 𝗛𝘂𝗺𝗮𝗻 𝘁𝗶𝘀𝘀𝘂𝗲 𝗽𝗿𝗼𝗼𝗳: ↳ Gingipain enzymes from P. gingivalis were identified in human brain tissue (Science Advances, 2019) 𝗖𝗹𝗼𝘁-𝗹𝗲𝘃𝗲𝗹 𝗽𝗿𝗼𝗼𝗳: ↳ Oral bacteria DNA detected directly inside blood clots from ischemic stroke patients 𝗥𝗶𝘀𝗸 𝗺𝗮𝗴𝗻𝗶𝘁𝘂𝗱𝗲: ↳ Periodontitis linked to 50-70% higher stroke risk, even after adjusting for smoking, diabetes, and blood pressure This suggests gum disease doesn't just travel alongside stroke risk. It likely contributes to it in at least some patients. 𝗧𝗛𝗘 𝗠.𝗢.𝗨.𝗧.𝗛. 𝗙𝗥𝗔𝗠𝗘𝗪𝗢𝗥𝗞 𝗠 — 𝗠𝗼𝗻𝗶𝘁𝗼𝗿 𝗯𝗹𝗲𝗲𝗱𝗶𝗻𝗴 ↳ Bleeding gums increase the chance oral bacteria enter your bloodstream ↳ Track which areas bleed and address them 𝗢 — 𝗢𝗽𝘁𝗶𝗺𝗶𝘇𝗲 𝗯𝗿𝘂𝘀𝗵𝗶𝗻𝗴 ↳ Electric toothbrush, 2 minutes, twice daily ↳ 45-degree angle at the gumline 𝗨 — 𝗨𝗻𝗱𝗲𝗿𝗻𝗲𝗮𝘁𝗵 𝗺𝗮𝘁𝘁𝗲𝗿𝘀 ↳ Floss daily ↳ Periodontal bacteria thrive where brushes can't reach 𝗧 — 𝗧𝗿𝗲𝗮𝘁 𝗶𝗻𝗳𝗹𝗮𝗺𝗺𝗮𝘁𝗶𝗼𝗻 𝗲𝗮𝗿𝗹𝘆 ↳ Bleeding beyond 2 weeks = dental review ↳ Don't wait for pain 𝗛 — 𝗛𝗮𝗹𝗳-𝘆𝗲𝗮𝗿𝗹𝘆 𝗰𝗹𝗲𝗮𝗻𝗶𝗻𝗴𝘀 ↳ Every 6 months routinely ↳ High cardiovascular risk: every 3-4 months 𝗪𝗛𝗔𝗧'𝗦 𝗖𝗛𝗔𝗡𝗚𝗜𝗡𝗚 𝗜𝗡 𝗠𝗘𝗗𝗜𝗖𝗜𝗡𝗘 Some cardiology and stroke teams now ask about oral health during cardiovascular risk assessments. ↳ Basic periodontal screening for high-risk patients ↳ Earlier treatment of gum inflammation ↳ Growing recognition that mouth health influences vascular health The goal isn't perfect teeth. It's reducing chronic inflammation at the source before it spreads downstream. Stroke prevention isn't just about cholesterol numbers. It's understanding how inflammation in one system amplifies disease in another. 💾 Save this for the next time you skip flossing because you're too tired ➕ Follow Dr Tim Patel for stories that turn hard science into action.

One twin watches her body fail while her identical sister stays perfectly healthy. Scientists just discovered the difference lives in their gut. Two bacteria turning the brain against itself. Think about that. German researchers recruited 81 pairs of identical twins where only one twin had MS—stripping away genetic confusion to expose what really causes MS. They discovered over 50 bacterial differences between affected and unaffected twins, with Eisenbergiella tayi and Lachnoclostridium species standing out as potential MS triggers. Traditional MS Reality: ↳ 2.8 million people affected worldwide ↳ Cause labeled "multifactorial mystery" ↳ Immune suppressants manage symptoms ↳ Progressive disability often inevitable The Microbiome Discovery: ↳ Specific bacteria enriched in MS twins ↳ Transplanted gut microbes trigger disease in mice ↳ Female mice particularly susceptible ↳ Direct gut-brain-immune connection proven But here's what grabbed me: When researchers transplanted gut bacteria from MS twins into germ-free mice, the animals developed MS-like disease. Not from genetics. Not from environment. From microbes alone. The bacteria from healthy twins? Protected the mice. Even more striking: Eisenbergiella tayi, barely detectable in human samples, became dominant in sick mice. A minor player in our gut turning the brain against itself. What changes everything: ↳ MS risk potentially measurable through stool samples ↳ Targeted antibiotics or bacteriophages possible ↳ Precision probiotics to outcompete harmful strains ↳ Prevention before symptoms, not just management The Multiplication Effect: 1 microbiome test = early risk detection 10 targeted interventions = personalized prevention 100 research centers refining = MS becoming preventable At scale = autoimmune diseases decoded through gut bacteria For decades, families watched one twin deteriorate while the other stayed healthy, wondering why their identical biology diverged. Now we know: the difference might be microscopic residents in their intestines. We spent 150 years treating MS as an inevitable brain disease. Now it might be a treatable gut imbalance. Because when identical DNA produces different diseases based on gut bacteria, you realise: The code for MS isn't just written in our genes. It's growing in our gut. Follow me, Dr. Martha Boeckenfeld for innovations where microscopic discoveries transform human health. ♻️ Share if you believe the next medical revolution lives in our gut, not our pharmacy. Resource: Kleinewietfeld, M., et al. (2024). Specific gut bacteria from multiple sclerosis patients modulate human T cell function and exacerbate symptoms in a mouse model. Proceedings of the National Academy of Sciences, 121(48), e2419689122.

When gut imbalance turns into whole-body inflammation This figure shows how an unhealthy gut microbiome can set off a chain reaction that affects metabolism, hormones, and nearly every major organ system. When the gut barrier weakens, bacterial toxins leak into the bloodstream, driving a cycle of chronic inflammation, hormonal resistance, and metabolic dysfunction. 1️⃣ From balance to breakdown A healthy gut microbiota produces short-chain fatty acids and bile acid derivatives that regulate appetite, blood sugar, and immunity. Poor diet and nutrient overload disrupt this balance, reducing beneficial bacteria and allowing harmful species to dominate. 🟢 Example: Loss of SCFA-producing microbes weakens the intestinal barrier and reduces signals like GLP-1 that help control hunger and glucose levels. 2️⃣ Leaky gut and metabolic endotoxemia When the gut lining becomes permeable, bacterial fragments such as LPS (lipopolysaccharides) enter the bloodstream and activate immune receptors. The result is a state of chronic low-grade inflammation. 🟢 Example: Elevated LPS stimulates immune cells to release TNF-α and IL-6, cytokines that cause insulin resistance and fat storage. 3️⃣ Adipose tissue and hormone disruption Inflamed fat tissue releases inflammatory cytokines and interferes with hormones that regulate appetite and metabolism. 🟢 Example: Leptin resistance blunts satiety signals in the brain, promoting overeating, while cortisol and insulin changes reinforce fat accumulation. 4️⃣ Systemic effects beyond the gut Inflammation from the gut spreads to the liver, pancreas, muscles, and brain, disrupting organ function. 🟢 Example: In the liver, it promotes fatty liver disease; in the pancreas, it impairs insulin secretion; in the brain, it contributes to mood and appetite dysregulation. 5️⃣ Metaflammation — the chronic loop Persistent gut inflammation evolves into metaflammation, a systemic state of metabolic stress that underlies obesity, insulin resistance, infertility, and neuroinflammation. 🟢 Example: This feedback loop connects gut health directly to weight regulation, reproductive function, and cognitive decline. In short, gut dysbiosis doesn’t stay in the gut. It fuels a metabolic storm that links poor diet and inflammation to obesity, hormonal imbalance, and disease throughout the body. Citation: Tian, Y., Xu, Z., Li, S., et al. Metaflammation: Chronic low-grade inflammation in metabolic disorders. Pharmacological Research, 2023; 187:106552.

Biodiversity loss kills 🌍💀: This is the story of how the near-extinction of a single bird species led to 100,000 human deaths per year in India.🇮🇳   In the 90s, the number of Indian vultures in the wild fell by over 95%. It turned out, that vultures died because of the use of the painkiller in veterinary clinics. Treating cattle with diclofenac produced carcasses that were deadly to vultures. Vultures provided an important public health service by removing livestock carcasses, which helps prevent water pollution and the spread of infectious diseases.   Two economists estimated that human death rates rose by over 4% in areas where vultures were common.   This implies an average of 104,386 additional deaths a year. 😲   💡Thus, the loss of a single bird species can be catastrophic for public health.   The story of the Indian vultures teaches us that, in an era of mass extinctions, we need more than ever policies that protect biodiversity.   Source: Eyal Frank and Anant Sudarshan, 2024, The social costs of keystone species collapse: Evidence from the decline of vultures in India., forthcoming American Economic Review.

A groundbreaking analysis on the link between biodiversity 🦇 and human well-being was published this week in Science. Bats, often overlooked in biodiversity discussions, play a critical role as natural pest controllers—benefiting both the economy and human health. Eyal Frank, known for his work linking vulture declines to human mortality in India, illustrates the cascading effects of biodiversity loss on agriculture and public health, using the decline of bat populations in the U.S. due to white-nose syndrome as a case study. The findings are alarming. Between 2006 and 2017, counties affected by white-nose syndrome, a fungal disease decimating bat populations, saw a 31% rise in insecticide use. Farmers, deprived of the pest control provided by bats, turned to chemicals as a substitute. However, this stopgap came at a steep cost—not just financially. The study shows infant mortality rates in those counties increased by nearly 8%, resulting in 1,334 additional infant deaths during this period, a grim consequence of increased chemical exposure. Frank aimed to quantify both the economic and human costs of losing this vital ecosystem service. His work illustrates the interconnectedness of biodiversity and human well-being. With fewer bats to prey on insects, crop revenues in affected areas dropped by 28.9%, with total agricultural losses estimated at $26.9 billion. The compensatory rise in insecticide use failed to fully replace the lost pest control and likely worsened declines in crop quality and farm revenue. While much of the biodiversity conversation focuses on species loss, this research underscores broader impacts, extending to agricultural productivity and public health. It serves as a stark warning to policymakers about the hidden costs of biodiversity decline. As efforts to protect 30% of the planet’s land and marine ecosystems by 2030 gain momentum, studies like this provide crucial evidence that conservation is not just about saving species but also safeguarding human life and livelihoods. Key Figures: 👉 31% increase in insecticide use in affected counties. 👉 8% rise in infant mortality in those same regions. 👉 1,334 additional infant deaths attributed to bat population declines. 👉 28.9% drop in crop revenue in areas impacted by white-nose syndrome. 👉 Estimated agricultural losses of $26.9 billion between 2006 and 2017. Eyal G. Frank. The economic impacts of ecosystem disruptions: Costs from substituting biological pest control. Science. 6 Sep 2024 Vol 385, Issue 6713 DOI: 10.1126/science.adg034 🔗 https://lnkd.in/gn4Kh5xE

🧠 𝗬𝗼𝘂𝗿 𝗺𝗼𝘂𝘁𝗵 𝗰𝗮𝗻 𝘄𝗮𝗿𝗻 𝘆𝗼𝘂 𝗯𝗲𝗳𝗼𝗿𝗲 𝘆𝗼𝘂𝗿 𝗯𝗿𝗮𝗶𝗻 𝗱𝗼𝗲𝘀. A new 21 year study of nearly 6,000 adults found that people with both gum disease (periodontitis) and untreated tooth decay had an 86% higher risk of ischemic stroke, compared with individuals with healthy mouths. Those with gum disease alone saw a 44% increased risk. Here’s what it really means for dental-professionals, patients and everyday life: Oral health isn’t just about “a nice smile” or “no cavities” it can be a window into systemic vascular health. Inflammation and bacterial load from gum disease + decay may travel beyond the mouth and increase vascular risk. Regular dental checks and effective tooth & gum care matter this isn’t optional if you want to move beyond “teeth only” and help patients protect their brain health. As a dentist & implantologist, I see it in practice: the same patient who neglects extractions, fillings or deep-cleaning may also present with silent vascular risks we don’t always talk about. So here’s a call to action I’d put in front of every patient: “We fix your smile, but we’re also safeguarding your brain, your circulation, your future.” 𝗠𝘆 𝗽𝗿𝗼𝗳𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹 𝘁𝗮𝗸𝗲𝗮𝘄𝗮𝘆: Let’s broaden the narrative. When I assess and plan implant or prosthetic treatments, I now also ask: “How’s your gum health? How many cavities are untreated? When was your last deep clean?” Because the mouth body connection is real. Let’s partner with physicians, neurologists and cardiologists more often help patients understand that “brushing + cleaning” isn’t just dental hygiene, it’s brain protection. #OralHealth #StrokePrevention #Dentistry #Implantology #PublicHealth

Dietary fiber intake has declined globally, paralleled by rising incidence of inflammatory bowel disease (IBD), allergies, and autoimmune diseases. Chronic inflammation is central to immune-mediated disease, and fiber modulates the gut microbiome to influence inflammatory processes. The gut microbiota metabolize fiber into short-chain fatty acids (SCFAs), which act as pivotal mediators linking diet, microbes, and host physiology. High-fiber regimens, such as Mediterranean and plant-based diets, consistently increase microbiome diversity and enrich SCFA-producing taxa, supporting intestinal barrier function and immune regulation. In inflammatory diseases, higher fiber intake is associated with reduced inflammatory markers (e.g., CRP, MCP-1, IL-18, IL-33) and improved disease activity indices in UC/CD and murine models. Whole-diet high-fiber interventions generally yield larger microbiome and clinical benefits than fiber supplements; effects vary with dosage, fiber type, and intervention duration. SCFAs cross the blood–brain barrier, potentially influencing microglial maturation and neuroinflammation. Dietary fiber shapes the gut ecosystem and inflammatory health primarily through SCFA-mediated mechanisms; realizing its therapeutic potential requires clear, personalized dietary strategies and robust clinical trials. SOURCE: F. Zhang et al. (2022). "The Gut Microbiome: Linking Dietary Fiber to Inflammatory Diseases." Medicine In Microecology. doi: 10.1016/j.medmic.2022.100070.

The next $9B healthcare revolution isn’t coming from a new drug. It’s coming from your gut. I spent the week going through Scope Forward's new report on the microbiome market and the signal is unmistakable. This isn’t a fringe niche anymore. It’s becoming one of the fastest-growing categories in healthcare. A $1.6B market in 2025 growing to almost $9B by 2034. That’s biotech-scale expansion hiding inside an organ most of us barely learned about in training.  What’s driving the surge: • FDA-approved therapeutics from Rebiotix Inc (a Ferring Company) (Ferring and Seres Therapeutics (  Vowst and Reybota )  • AI platforms like Jona, Iom Bioworks, and Microba building “digital twins” of the gut • CRISPR-driven engineering from groups like SNIPR Biome - A CRISPR Company • Personalized nutrition and wellness platforms like Zoe, Supergut, Pendulum Therapeutics, and Viome - which also has FDA Breakthrough Device designation for early cancer detection, plus partnerships with GSK, Scripps Health, and Mayo Clinic • Early-life gut health innovation from Tiny Health • Multi-omic testing platforms from Clinical Microbiomics, CosmosID, Inc., and Microbiome Insights Inc. • Diagnostics companies pushing the field forward, like PreciseDx and 32 Biosciences "Three Squared" The common theme is scale. These aren’t small labs anymore. They’re mature platforms with investors, clinical pipelines, regulatory pathways, and rapidly expanding real-world use cases. And the clinical implications are massive.The report calls the microbiome a “healthcare operating system” After reading it, that no longer feels like an exaggeration.  A few patterns stand out: • GLP-1 response is increasingly predictable by baseline gut signatures • Post-GLP-1 weight regain tracks with microbial diversity loss • IBS, IBD, NAFLD, and metabolic disease all show microbiome-linked phenotypes • Infant and maternal gut health is becoming its own specialty • Smart sensors, at-home sequencing, and AI interpretation are pulling this into routine care fast For clinicians ,a new field is forming, and GI is at the center of it. For startups, regulatory clarity plus market pull is rare ,and it’s happening now. For patients, we’re moving toward more personal, precise, preventive care. Full report is linked in the comments, its a must read for anyone building in the space.